Navigation Links
NCI Renews Mayo Clinic Cancer Center Support Grant, Extends Comprehensive Status
Date:7/6/2009

ROCHESTER, Minn., July 6 /PRNewswire-USNewswire/ -- The Mayo Clinic Cancer Center (MCCC) received an additional five years of National Cancer Institute (NCI) funding and re-designation as a comprehensive cancer center, according to Robert Diasio, M.D., the center's director. Mayo Clinic has the only NCI-designated comprehensive cancer center conducting research at three distinct locations across the United States.

The NCI Cancer Center Support Grant award to MCCC totals more than $28 million over five years for infrastructure and administrative support for cancer center researchers across Mayo's three sites in Minnesota, Florida and Arizona.

"The NCI renewal of Mayo's Cancer Center Support Grant ensures the continuity of research programs that contribute to improved medical options for cancer patients," Dr. Diasio says. "This NCI grant is key in enabling Mayo Clinic to continue delivering outstanding care for its cancer patients."

The MCCC is headquartered in Rochester, Minn., with research campuses in Scottsdale, Ariz., and Jacksonville, Fla. With NCI approval in 2003, MCCC incorporated its cancer research activity at its Minnesota, Florida and Arizona sites into a single, integrated institution.

"The NCI recognized the Mayo Clinic Cancer Center for excellence in basic and clinical research, and for our contributions to cancer prevention, control and population sciences," Dr. Diasio says. "This award enables Mayo cancer researchers on all three of our campuses to build upon knowledge that leads to changes in medical practice which means improved treatment opportunities for our patients."

Within its scope as a NCI-designated comprehensive cancer center, the MCCC designs and develops translational clinical studies that arise from collaborations between scientists and physicians.

The 450 scientists and physicians of the MCCC faculty across all three sites are organized into programs that focus on 12 key cancer research themes. They include Women's Cancers, Neuro-Oncology, Hematologic (bloodborne) Malignancies, Gene and Virus Therapy, Developmental Therapeutics, Genetic Epidemiology and Risk Assessment, Immunology and Immunotherapy, Gastrointestinal Cancers, Prostate Cancer, Cell Biology, Cancer Imaging, and Cancer Prevention and Control.

About Mayo Clinic

Mayo Clinic is the first and largest integrated, not-for-profit group practice in the world. Doctors from every medical specialty work together to care for patients, joined by common systems and a philosophy of "the needs of the patient come first." More than 3,300 physicians, scientists and researchers and 46,000 allied health staff work at Mayo Clinic, which has sites in Rochester, Minn., Jacksonville, Fla., and Scottsdale/Phoenix, Ariz. Collectively, the three locations treat more than half a million people each year. To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news. For information about research and education visit www.mayo.edu. MayoClinic.com (www.mayoclinic.com) is available as a resource for your health stories.


'/>"/>
SOURCE Mayo Clinic
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NCI renews Mayo Clinic Cancer Center support grant, extends comprehensive status
2. Cardinal Health Renews Distribution Agreement With CVS Caremark
3. The European Association for the Study of the Liver renews publishing partnership with Elsevier
4. Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream
5. DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm
6. New York Merchants Protective Co. Renews CSAA Five Diamond Certification
7. Specialists On Call Renews Joint Commission Accreditation
8. New book series renews call for ban on gambling
9. Doctor Diabetic Supply, Inc. Renews its ACHC Accreditation
10. American TeleCare, Inc. (ATI) Renews Agreements for its Telehealth Solutions with the Veterans Health Administration
11. Rochester Medical Renews Share Repurchase Activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... Breast Cancer Conference from Sept. 18 to 20. , The two-day conference is ... subtype with the goal of improving patients’ lives and eliminating racial breast cancer-related ...
(Date:6/23/2017)... Monica, CA (PRWEB) , ... June 23, 2017 , ... ... as the endorsed amalgam separator supplier for CDA members. As part of the amalgam ... reduced price of $99, saving more than $400 off the retail value. This partnership ...
(Date:6/23/2017)... San Francisco, CA (PRWEB) , ... June 23, 2017 , ... ... Conference on 26th June, 2017 from 9 am to 3 pm to present to ... curriculum. The program is an original curriculum project led by The Health Improvement ...
(Date:6/23/2017)... Gilmer, TX (PRWEB) , ... June 23, 2017 , ... ... consultations to residential and business clients throughout eastern Texas, is announcing the launch of ... , Recent breast cancer statistics in the United States reveal that an estimated ...
(Date:6/22/2017)... Miami, FL (PRWEB) , ... June 22, 2017 , ... ... has received more than $245,000 in grant funding to support its programs focused on ... recently, Branches, Inc. was awarded a grant by the Foundation of $15,000 to support ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)...  Novavax, Inc., (Nasdaq: NVAX ) today announced ... of its RSV F protein recombinant nanoparticle vaccine candidate (RSV ... published in the journal Vaccine (the ... scientific conferences). The Company previously announced top line results ... the RSV F Vaccine with the goal of protecting infants ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq: ... care, today announced new findings demonstrating positive biochemical outcomes ... System One™. The data will be presented at ... Madrid, Spain . ... Improve Home Dialysis Network in Europe ...
(Date:5/29/2017)...  Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: ... functional selection of stem cells, today provided a corporate ... ended March 31 st , 2017. ... first quarter of 2017," said Dr. Shai Yarkoni, Chief ... treatment of the first blood cancer patient in the ...
Breaking Medicine Technology: